ANKTIVA® Global Availability
Where ANKTIVA® (nogapendekin alfa inbakicept) is Approved or Authorized
ANKTIVA® has been approved or authorized across multiple regulatory jurisdictions, representing more than 30 countries and territories
European Union
Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia (Czech Republic), Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Iceland, Liechtenstein, Norway
United Kingdom
United States
Kingdom of Saudi Arabia
United Arab Emirates
Regulatory approvals and indications for ANKTIVA® vary by jurisdiction. The information provided is for transparency and reference purposes only and does not constitute promotional material or medical advice.
Last Updated: August 2026